Severe Adverse Reaction to Vemurafenib in a Pregnant Woman with Metastatic Melanoma

Targeted therapies have drastically changed the management of metastatic melanoma and have shown encouraging results on tumour progression but are also known for their high rates of adverse reactions. In general, targeted therapies are contraindicated during pregnancy due to concerns about teratogen...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Case Rep Oncol
Autori principali: de Haan, Jorine, van Thienen, Johannes V., Casaer, Michael, Hannivoort, Rebekka A., Van Calsteren, Kristel, van Tuyl, Minke, van Gerwen, Mathilde M., Debeer, Anne, Amant, Frédéric, Painter, Rebecca C.
Natura: Artigo
Lingua:Inglês
Pubblicazione: S. Karger AG 2018
Soggetti:
Case Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5869570/
https://ncbi.nlm.nih.gov/pubmed/29606950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000487128
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi